Teva aims to give people coping with respiratory diseases a more effective role in their own treatment. We do this by taking inspiration from the everyday experiences of patients coping with respiratory disease.
The more we understand the reality of what patients experience in managing conditions – like COPD & asthma – the easier it is to find pragmatic, innovative solutions to help healthcare professionals help patients in their fight for breath.
At Teva, we’re combining our strengths in specialty medicines, device platforms and patient support programmes to develop new treatment options that help people with respiratory diseases breath easier.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a global leader in generic medicines, with innovative treatments in select areas, including CNS, pain and respiratory. We deliver high-quality generic products and medicines in nearly every therapeutic area to address unmet patient needs. We have an established presence in generics, specialty, OTC and API, building on more than a century-old legacy, with a fully integrated R&D function, strong operational base and global infrastructure and scale. We strive to act in a socially and environmentally responsible way. Headquartered in Israel, with production and research facilities around the globe, we employ 45,000 professionals, committed to improving the lives of millions of patients. Learn more at www.tevapharm.com.